Anti-ICAM5/ TLCN/ TLN monoclonal antibody

Anti-ICAM5/ TLCN/ TLN antibody for FACS & in-vivo assay

Target products collectionGo to ICAM5/ICAM5 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0600-Ab-1/ GM-Tg-hg-MP0600-Ab-2Anti-Human ICAM5 monoclonal antibodyHuman
GM-Tg-rg-MP0600-Ab-1/ GM-Tg-rg-MP0600-Ab-2Anti-Rat ICAM5 monoclonal antibodyRat
GM-Tg-mg-MP0600-Ab-1/ GM-Tg-mg-MP0600-Ab-2Anti-Mouse ICAM5 monoclonal antibodyMouse
GM-Tg-cynog-MP0600-Ab-1/ GM-Tg-cynog-MP0600-Ab-2Anti-Cynomolgus/ Rhesus macaque ICAM5 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0600-Ab-1/ GM-Tg-felg-MP0600-Ab-2Anti-Feline ICAM5 monoclonal antibodyFeline
GM-Tg-cang-MP0600-Ab-1/ GM-Tg-cang-MP0600-Ab-2Anti-Canine ICAM5 monoclonal antibodyCanine
GM-Tg-bovg-MP0600-Ab-1/ GM-Tg-bovg-MP0600-Ab-2Anti-Bovine ICAM5 monoclonal antibodyBovine
GM-Tg-equg-MP0600-Ab-1/ GM-Tg-equg-MP0600-Ab-2Anti-Equine ICAM5 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0600-Ab-1/ GM-Tg-hg-MP0600-Ab-2; GM-Tg-rg-MP0600-Ab-1/ GM-Tg-rg-MP0600-Ab-2;
GM-Tg-mg-MP0600-Ab-1/ GM-Tg-mg-MP0600-Ab-2; GM-Tg-cynog-MP0600-Ab-1/ GM-Tg-cynog-MP0600-Ab-2;
GM-Tg-felg-MP0600-Ab-1/ GM-Tg-felg-MP0600-Ab-2; GM-Tg-cang-MP0600-Ab-1/ GM-Tg-cang-MP0600-Ab-2;
GM-Tg-bovg-MP0600-Ab-1/ GM-Tg-bovg-MP0600-Ab-2; GM-Tg-equg-MP0600-Ab-1/ GM-Tg-equg-MP0600-Ab-2
Products NameAnti-ICAM5 monoclonal antibody
Formatmab
Target NameICAM5
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-ICAM5 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species ICAM5/ TLCN/ TLN VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLP001525human ICAM5 Lentivirus plasmid
    ORF Viral VectorvGMLP001525human ICAM5 Lentivirus particle


    Target information

    Target IDGM-MP0600
    Target NameICAM5
    Gene ID7087,15898,720495,484958,101089676,505158,100146897
    Gene Symbol and SynonymsCD50,ICAM-3,ICAM-5,Icam3,ICAM5,TLCN,TLN
    Uniprot AccessionQ9UMF0
    Uniprot Entry NameICAM5_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000105376
    Target ClassificationN/A

    The target: ICAM5, gene name: ICAM5, also named as TLCN, TLN. The protein encoded by this gene is a member of the intercellular adhesion molecule (ICAM) family. All ICAM proteins are type I transmembrane glycoproteins, contain 2-9 immunoglobulin-like C2-type domains, and bind to the leukocyte adhesion LFA-1 protein. This protein is expressed on the surface of telencephalic neurons and displays two types of adhesion activity, homophilic binding between neurons and heterophilic binding between neurons and leukocytes. It may be a critical component in neuron-microglial cell interactions in the course of normal development or as part of neurodegenerative diseases. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.